New FSGS Treatment: Micro-Chinese Medicine Osmotherapy

Nowadays, FSGS has become a common cause for kidney failure requiring dialysis or kidney transplant. Some FSGS patients find that there is still lots of proteinuria though taking the western medications regularly. Here we will talk about the treatment options for FSGS.
ACEIs and ARBs are nonspecific agents that reduce proteinuria because of their antihypertensive and intrarenal hemodynamic effects of reducing glomerular capillary pressure and resistance. ACEIs and ARBs are effective in reducing protein loss even in normotensive patients. These agents do not eliminate proteinuria completely or reverse the primary glomerular disease process.
Since most patients with idiopathic FSGS develop hypertension, which further contributes to renal functional deterioration, meticulous attention must be paid to maintain BP in the reference range. All classes of antihypertensive agents, which effectively lower BP, have a beneficial effect in reducing proteinuria. In many patients, combination antihypertensive therapy may be needed to maintain normal blood pressure.
Another nonspecific therapy is the use of lipid-lowering agents to control hyperlipidemia. The statin class of drugs is better tolerated than some of the older agents.

Micro-Chinese Medicine Osmotherapy is a new treatment for FSGS. It is a new development of Chinese herbal medicines, but used externally. It aims at removing immune complexes out of body, repairing kidney damage and recovering renal function, thus helping FSGS patients effectively avoid dialysis and kidney transplant. You are welcomed to click how does Micro-Chinese Medicine Osmotherapy work to learn more. If having any questions about FSGS treatment, you can directly consult online doctor for free or email us to kidneyhospitalabroad@hotmail.com, we are glad to help.